ORIGINAL RESEARCH article
Front. Med.
Sec. Ophthalmology
This article is part of the Research TopicImaging in the Diagnosis and Treatment of Eye DiseasesView all 39 articles
Exploring Potential Imaging Biomarkers for Ischemic Retinal Vein Occlusion: Insights from Fundus Autofluorescence and Optical Coherence Tomography
Provisionally accepted- 1Tianjin Medical University Eye Hospital, Tianjin, China
- 2Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, China, Wuhan, China
- 3Handan Eye Hospital (The Third Hospital of Handan), Handan, China
- 4The First Affiliated Hospital of Dalian Medical University, Dalian, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Purpose: This study aimed to investigate the characteristics of macular edema observed by fundus autofluorescence (FAF) and to analyze noninvasive indicators of ischemia in retinal vein occlusion (RVO) through FAF or optical coherence tomography (OCT). We specifically report a newly recognized FAF–OCT mismatch in ischemic RVO, in which CME is not detectable on FAF. Methods: This study included 74 participants. 49 eyes of 49 patients with RVO and 25 healthy control eyes were included in the study. All patients underwent a complete ophthalmologic examination and were evaluated with FAF, fundus fluorescein angiography (FFA), and OCT. The optical intensities of the inner and outer retinal layers were measured using ImageJ software. Results: Of 49 eyes in RVO patients, FAF imaging showed typical Cystoid macular edema (CME) with hyperautofluorescence in non-ischemic RVO patients (69.57%) and in ischemic RVO patients (26.92%, p=0.029, p<0.05). Disorganization of retinal inner layers (DRIL) was observed in 13 eyes in the non-ischemic RVO group and 23 eyes in the ischemic RVO group. (χ ²=6.387, p=0.012, p<0.05) The prominent middle-limiting membrane (p-MLM) sign was found in 5 eyes in the non-ischemic RVO group and 15 eyes in the ischemic RVO group. (χ ²=6.530, p=0.011, p<0.05) The mean optical intensity of the retinal pigment epithelium (RPE) layer, ellipsoid, and interdigitation zones in the ischemic RVO group was 109.78 ± 19.327, which was significantly lower compared to the non-ischemic RVO group (172.31 ± 30.527, p = 0.001, p < 0.01). Conclusions: CME in patients with ischemic RVO is less easily detectable on FAF compared to patients with non-ischemic RVO. This lack of correspondence may provide insight into the type of RVO. We conclude that the presence of DRIL, a p-MLM sign, impairment of the integrity of the external limiting membrane (ELM), and decreased optical intensity or integrity of the ellipsoid zone and RPE can serve as effective indicators of ischemia in RVO patients.
Keywords: disorganization of retinal innerlayers, Fundus autofluorescence, Optical Coherence Tomography, prominent middle-limiting membrane, Retinal Vein Occlusion
Received: 17 Oct 2025; Accepted: 01 Dec 2025.
Copyright: © 2025 Wang, Zhou, Hu, Ding, Zhang, Wei, Qin and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xiaoling Zhang
Ruihua Wei
Xiuhong Qin
Zhiqing Li
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.